Antileukotriene drugs and Churg-Strauss syndrome;Leki antyleukotrienowe a zespół Churga i Strauss

Polskie Archiwum Medycyny Wewnetrznej

Volumn 107, Issue 2, 2002, Pages 173-176

  Mastalerz, Lucyna ^a   Świerczyńska, Monika ^a   Nizankowska Mogilnicka, Ewa ^a  

^a NONE

Author keywords

Antileukotriene drugs; Churg Strauss syndrome

Indexed keywords

DRUG DERIVATIVE; HYDROXYUREA; LEUKOTRIENE RECEPTOR BLOCKING AGENT; ZILEUTON;

CHURG STRAUSS SYNDROME; HUMAN; REVIEW;

CHURG-STRAUSS SYNDROME; HUMANS; HYDROXYUREA; LEUKOTRIENE ANTAGONISTS;

EID: 1342304738     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Rekowska D., Kucharz E.J.: Zespół Churg i Strauss. Pol. Arch. Med. Wewn., 1998, 100, 272.
2. Zielonka T.M., Da̧browski A., Droszcz W.: Trudności w rozpoznawaniu zespołu Churg-Strauss, Pneum. Alergol. Pol., 1991, 59, 224.
3. Obła̧kowski P., Wiatr E., Decker E. i wsp.: Zespół Churg-Strauss nie reaguja̧cy na leczenie immunosupresyjne. Pneum. Alergol. Pol., 1994, 62, 98.
4. Syrenicz A., Eisner M., Pynka S. i wsp.: Zespół Churg-Strauss: opis dwóch przypadków, Pol. Tyg. Lek., 1994, 49, 345.
5. Grabowska B., Razny M.: Zespół Churg-Strauss. Wiad. Lek., 1997, 50, 42.
6. Specks U.: Pulmonary vasculitis. [w:] Schwartz M.I., King T.E. (red.) Interstitial lung Disease. BC Decker Inc., Hamilton, 1998, s.507.
7. Lynch J.P., Fantone J.: Other pulmonary granulomatous vasculitides. [w:] Lynch J.P., DeRemee R.A. (red.), Immunologically mediated pulmonary diseases. JB Lippincott Company, Philadelphia, 1992, s.314.
8. Churg J., Strauss L.: Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am. J. Pathol., 1951, 27, 277.
9. Hart B.: Replacing or reducing the high dose oral corticosteroids with alternative asthma treatment asthma controller therapies: implications for leukotriene receptor antagonists. Eur. Respir. J., 1998, 8, 1056.
10. Masi A.T., Hunder G.G., Lie J.T. i wsp.: The American College of Rheumatology 1990 Criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum., 1990, 33, 1094.
11. Lankam J.G., Elkon K.B., Pusey C.D. i wsp.: Systemic vasculitis with asthma and eosinophila: a clinical approach to the Churg-Strauss syndrome. Medicine, 1984, 63, 65.
12. Guillevin L., Cohen P., Gayraud M. i wsp.: Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine, 1999, 78, 26.
13. Choi Y.H. Im J.G., Han B.K. i wsp.: Thoracic manifestation of Churg-Strauss syndrome: radiologic and clinical findings. Chest, 2000, 117, 117.
14. Arm J., Mark E.J.: Weekly clinicopathological exercises: case 30-2000: a 25-year-old man with asthma, cardiac failure, diarrhea, and weakness of the right band. N. Eng. J. Med., 2000.
15. Guillevin L., Lhote F., Gayraud M. i wsp.: Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine, 1996, 75, 17.
16. Gayraud M., Guillevin L., le Toumelin P. i wsp.: Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum., 2001, 44, 666.
17. Tsukadaira A., Okubo Y., Kitano K. i wsp.: Eosinophil active cytokines and surface analysis of eosinophils in Churg-Strauss syndrome. All. Asthma Proc., 1999, 20, 39.
18. Schmitt W.H. Csernok E., Kobayshi S. i wsp.: Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage. Arthitis Rheum., 1998, 41, 445.
19. Hurst S., Chizzolini C., Dayer. i wsp.: Usefulness of serum eosinophil cationic protein (ECP) in predicting relapse of Churg and Strauss vasculitis. Clin. Exp. Rheum., 2000, 18, 784.
20. Kiene M., Csernok E., Muller A. i wsp.: Elevated interleukin-4 and interleukin-13 production by T-cels lines from patients with Churg-Strauss syndrome. Arthritis Rheum., 2001, 44, 469.
21. Sorkness C.A.: Leukotriene receptor antagonista in the treatment of asthma. Pharmacoth., 2001, 21, 34.
22. Lipworth B.J.: Leukotriene-receptor antagonista. Lancet, 1999, 353, 57.
23. Dahlen S.E., Malstrom K., Kuna P. i wsp.: Improvement of asthma in aspirin-intolerant patients by montelukast (MK-0476) a potent and specific cys-LT 1 receptor antagonist: Correlation with patient's baseline characteristics. Eur. Respir. J., 1997,10, 4195.
24. Josefson D.: Asthma drug linked with Churg-Strauss syndrome. 1997, 315, 330.
25. Wechsler M.E., Garpestad E., Flier S.R. i wsp.: Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid with drawal in patients with asthma receiving zafirlukast. JAMA, 1998, 279, 455.
26. Franco J., Artes M.J.: Pulmonary eosinophilia associated with montelukast. Thorax, 1999, 54, 558.
27. Kinoshita M., Shiraishi T., Koga T. i wsp.: Churg-Strauss syndrome after corticostreoid with drawal in an asthmatic patient treated with pranlukast. J. All. Clin. Immunol., 1999, 103, 534.
28. Churg., A., Brallas M., Cronin S.R. i wsp.: Formes frustes of Churg-Strauss syndrome. Chest, 1995, 108, 320.
29. Wechsler M.E., Finn D., Gunawardena D. i wsp.: Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest, 2000, 117, 708.
30. Green R.L., Vayonis A.G.: Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment. Lancet, 1999, 353, 725.
31. Tuggey J.M., Hosker H. S.: Churg-Strauss syndrome associated with montelukast therapy. Thorax, 2000, 55, 805.
32. Stirling R.G., Chung K.F.: Leukotriene antagonists and Churg-Strauss syndrome: the smoking gun. Thorax, 1999, 54, 866.
33. Gruer P., Bold T. Vilardo L.: Case 30-2000: Churg-Strauss syndrome. N. Eng. J. Med., 2001, 344, 858.
34. Honsinger R. W.: Zafirlukast and Churg-Strauss syndrome. J. Am. Med. Assoc., 1998, 279, 1949.
35. Lee E.R.T., Smith J., Kilfeather S.: Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals. Am. J. Respir. Crit. Care. Med., 2000, 161, 1881.
36. Wechsler M., Drazen J.M.: Churg-Strauss syndrome. Lancet, 1999, 353, 1970.